Skip to main content

Table 1 IRS ratios of Th2/Th1 cytokines in control, untreated and nystatin-treated groups

From: Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis

Group Th2/Th1 IRS ratio P
Control 3.14 ± 2.57  
Untreated   
4 d 0.90 ± 0.26 0.004a
8 d 0.94 ± 0.70 0.005a
15 d 1.12 ± 0.62 0.009a
Treated 0.97 ± 0.31 0.840b
  1. The Th2/Th1 balance was determined by calculating the IRS ratios of IL-4/IFN-γ in different groups. aP < 0.05 compared with control group. bP > 0.05 compared with untreated 15 d sub-group. Data represent the mean ± standard deviation (n = 6)